Each month, during these 15-20 minute episodes, we delve into topics such as implicit bias in the workplace & patient care, designing and implementing a global teleneurology program, unbiased metagenomic next generation sequencing for diagnosis of CNS infection / inflammatory conditions, neurovirology, functional neuroimaging of functional movement disorders, and more! 

Eligible ANA Investigates episodes are designated for AMA PRA Category 1 Credit(s)™. The system to claim CME opens at the end of the year following the last episode of each calendar year. You have the ability to claim credit for all of season 3 in one simple evaluation.

The American Neurological Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS).

CME is available for the following episodes in season 3:

ANA Investigates Genetics in Epilepsies

Sep 27, 2022

The role of genetics in both pediatric and adult epilepsies is expanding. Now, making a genetic diagnosis in epilepsy isn’t just important for family planning and prognostication - these diagnoses can also improve patients’ care starting at the moment of diagnosis. Our guest today, Ingrid Scheffer, is a leader in...Read More

ANA Investigates Teleneurology and Healthcare Equity

Aug 29, 2022

Equitable tele-neurologic care starts with first identifying disparities, then identifying how to overcome them – learn about both with Dr. Lee Schwamm on the latest ANA Investigates. Series 3, Episode 11. Featuring:

• Guest: Dr. Lee Schwamm, C Miller Fisher Endowed Chair in Vascular Neurology and the Director of the...Read More

*Special Episode* ANA Investigates Potential Fabrication in AD Research Images

Aug 16, 2022

Late last month, the journal Science published an investigative report that accused a much-cited publication in Alzheimer’s disease... of fabricating scientific images. The study under scrutiny was published in Nature in 2006 by Sylvain Lesné and colleagues. It claimed that an amyloid oligomer called Aβ*56 impaired...Read More

ANA Investigates Updates in Autoimmune Encephalitis, part 2, therapeutics

Jul 26, 2022

Last month on the podcast, we talked about updates in the diagnosis of autoimmune encephalitis. This month we turn to advances in the treatment of autoimmune encephalitis. Treating these conditions has traditionally been practitioner-dependent, and currently no FDA-approved therapies exist. But that’s beginning to...Read More

ANA Investigates Updates in Autoimmune Encephalitis, part 1, diagnostics

Jun 27, 2022

On today's episode, Dr. Adeline Goss interviews Dr. Andrew McKeon on updates on diagnostics for part one of a two-part series on autoimmune encephalitis. Series 3, Episode 8. Featuring:

• Guest: Andrew McKeon, M.B., B.Ch., M.D., Mayo Clinic College of Medicine and Science
• Interviewer/Producer: Adeline Goss, MD,...Read More

ANA Investigates TIA

May 31, 2022

On today's episode, we discuss the term "TIA" and the current debate as it pertains to advances in stroke diagnostics that have led some to propose that we retire the term. Series 3, Episode 7. Featuring:

• Guest: Clay Johnston, MD, PhD, The University of Texas at Austin
• Interviewer/Producer: Megan Richie, MD, UCSF Read More

ANA Investigates Neurobiology of Burnout

Apr 12, 2022

Burnt out by talking about burnout? Please join us for a podcast with Dr. Amy Arnsten, Professor of Neuroscience and Psychology at Yale University, to investigate what goes on in the brain that leads to burnout and how this can direct our efforts to reduce burnout. Series 3, Episode 6. Featuring:

• Guest: Dr. Amy...Read More

ANA Investigates Biomarkers for Alzheimer's Disease

Mar 22, 2022

On today’s show, we’ll focus on the future of biomarkers in Alzheimer’s disease. We know that amyloid beta and tau protein deposit long before patients with Alzheimer’s develop symptoms. If we could use biomarkers to detect this pathology early, and treat patients early, could we prevent the progression to...Read More

ANA Investigates Curing Coma

Feb 21, 2022

Can coma be “cured”? On this podcast, we talk to Dr. Claude Hemphill and Dr. Romer Geocadin of the Curing Coma Campaign. Series 3, Episode 4 https://www.curingcoma.org/events2/world-coma-day

Featuring:

• Guests: Romer Geocadin, MD, Johns Hopkins University & Claude Hemphill, MD, University of California San...Read More

ANA Investigates Basilar Artery Stroke

Jan 18, 2022

Treatment of stroke has changed dramatically in the past decade, with the advent of perfusion imaging and an expanded time window for mechanical thrombectomy. Thrombectomy is now standard of care for eligible patients. But while data clearly supports the use of thrombectomy for certain patients with anterior...Read More

ANA Investigates FND

Dec 20, 2021

On today’s show we’ll focus on functional neurological disorder, or FND -- a wide range of conditions including non-epileptic seizures and functional weakness, dystonia and tremor. These conditions are common and can cause serious disability. But what are these conditions, exactly? What have functional neuroimaging...Read More

ANA Investigates Neurostimulation

Nov 15, 2021

Some patients with medically refractory epilepsy are offered surgeries to implant devices that electrically stimulate the nervous system and actually modulate neural networks over time. On this episode of ANA Investigates, Dr. Vikram Rao of the UCSF Weill Institute for Neurosciences discusses how these...Read More